Tim Germann has been named vice president of sales of Metabolon, the firm announced this week. Germann previously led sales and marketing at US Genomics, and has held sales positions at Affymetrix, Molecular Devices, Stratagene, and Incyte Genomics.
 

 
Affymetrix has named James Gibson its new financial accounting officer, the company said in a recent US Securities and Exchange Commission filing.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.